English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51923327    Online Users :  1267
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"jen chang ko"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 256-280 of 290  (12 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-11T07:58:34Z Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012 Lee M.-R.; Wang H.-C.; Yang C.-Y.; Lin C.-K.; Kuo H.-Y.; JEN-CHANG KO; Sheng W.-H.; Lee L.-N.; Yu C.-J.; Hsueh P.-R.
臺大學術典藏 2021-03-11T07:58:34Z Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells Chen R.-S.; JEN-CHANG KO; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Chen H.-J.; Huang Y.-C.; Jian Y.-J.; Lee W.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:34Z Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells JEN-CHANG KO; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Huang Y.-C.; Chen H.-J.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:33Z Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Jian Y.-J.; Chang P.-Y.; Wang T.-J.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:33Z Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination Lee M.-R.; Yang C.-Y.; Shu C.-C.; Lin C.-K.; Wen Y.-F.; Lee S.-W.; JEN-CHANG KO; Wang J.-Y.; Lee L.-N.; Yu C.-J.
臺大學術典藏 2021-03-11T07:58:33Z Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:33Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-11T07:58:33Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-11T07:58:32Z Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells JEN-CHANG KO; Chen J.-C.; Wang T.-J.; Zheng H.-Y.; Chen W.-C.; Chang P.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:32Z Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells JEN-CHANG KO; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:32Z Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells JEN-CHANG KO; Wang T.-J.; Chang P.-Y.; Syu J.-J.; Chen J.-C.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Zheng H.-Y.; Chen W.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:32Z Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities Lee M.-R.; Tsai C.-J.; Hu J.-Y.; Lee S.-W.; JEN-CHANG KO; Wang H.-C.; Yu C.-J.; Lee L.-N.; Hsueh P.-R.
臺大學術典藏 2021-03-11T07:58:31Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T07:58:31Z Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:31Z Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; Liang S.-K.; Liang M.-C.
臺大學術典藏 2021-03-11T07:58:30Z Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis Lee M.-R.; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; JEN-CHANG KO; Yu C.-J.; Lin H.-H.
臺大學術典藏 2021-03-11T07:58:30Z Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Wang J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T07:58:29Z Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Yu C.-J.
臺大學術典藏 2021-03-11T07:58:29Z Cementing an unwanted relationship Chang C.-H.; Keng L.-T.; JEN-CHANG KO
臺大學術典藏 2021-03-11T07:58:29Z Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan Lee M.-R.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Chang L.-Y.; Yu K.-L.; JEN-CHANG KO; Wang J.-Y.; Wang J.-T.; Lee L.-N.
臺大學術典藏 2021-03-11T07:58:28Z Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏 2021-03-11T07:58:28Z Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏 2021-03-11T07:58:28Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T07:58:27Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏 2021-03-11T07:58:27Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.

Showing items 256-280 of 290  (12 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page